- Home
- IMMX vs QMCO Comparison
IMMX vs QMCO Comparison
Compare IMMX & QMCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMX
- QMCO
- Stock Information
- Founded
- IMMX 2014
- QMCO 1980
- Country
- IMMX United States
- QMCO United States
- Employees
- IMMX N/A
- QMCO N/A
- Industry
- IMMX Medicinal Chemicals and Botanical Products
- QMCO Electronic Components
- Sector
- IMMX Health Care
- QMCO Technology
- Exchange
- IMMX Nasdaq
- QMCO Nasdaq
- Market Cap
- IMMX 61.1M
- QMCO 61.3M
- IPO Year
- IMMX 2021
- QMCO N/A
- Fundamental
- Price
- IMMX $2.65
- QMCO $7.53
- Analyst Decision
- IMMX Strong Buy
- QMCO Hold
- Analyst Count
- IMMX 1
- QMCO 2
- Target Price
- IMMX $7.00
- QMCO $19.00
- AVG Volume (30 Days)
- IMMX 220.7K
- QMCO 743.4K
- Earning Date
- IMMX 08-11-2025
- QMCO 08-12-2025
- Dividend Yield
- IMMX N/A
- QMCO N/A
- EPS Growth
- IMMX N/A
- QMCO N/A
- EPS
- IMMX N/A
- QMCO N/A
- Revenue
- IMMX N/A
- QMCO $285,865,000.00
- Revenue This Year
- IMMX N/A
- QMCO N/A
- Revenue Next Year
- IMMX N/A
- QMCO $2.46
- P/E Ratio
- IMMX N/A
- QMCO N/A
- Revenue Growth
- IMMX N/A
- QMCO N/A
- 52 Week Low
- IMMX $1.26
- QMCO $2.22
- 52 Week High
- IMMX $3.20
- QMCO $90.64
- Technical
- Relative Strength Index (RSI)
- IMMX 49.64
- QMCO 33.58
- Support Level
- IMMX $2.63
- QMCO $7.83
- Resistance Level
- IMMX $3.20
- QMCO $8.24
- Average True Range (ATR)
- IMMX 0.22
- QMCO 0.49
- MACD
- IMMX -0.04
- QMCO -0.09
- Stochastic Oscillator
- IMMX 3.51
- QMCO 3.38
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
About QMCO Quantum Corporation
Quantum Corp is a United States-based company that delivers end-to-end data management solutions designed for unstructured data. The company provides solutions for the entire data lifecycle. The company specialize in solutions for video, images, audio, and other large files. The company's portfolio of products includes primary storage software and systems, secondary storage software and systems, as well as devices and media. The company's Primary Storage Software and Systems include Myriad All-Flash Software-Defined Storage, StorNext Hybrid Flash/Disk File Storage Software, and Unified Surveillance Platform Software. Secondary Storage Software and Systems include ActiveScale Object Storage Software and DXi Backup Appliances. The firm derives the majority of its revenue from United States.